Hormone refractory prostatic cancer: The role of radiolabelled diphosphonates and growth factor inhibitors

H. I. Scher; T. Curley; S. Yeh; W. Tong; P. V. O'Moore; S. Larson

doi:10.1007/978-1-4615-3398-6_12

Hormone refractory prostatic cancer: The role of radiolabelled diphosphonates and growth factor inhibitors

H. I. Scher, T. Curley, S. Yeh, W. Tong, P. V. O'Moore, S. Larson

Cancer Systems Imaging

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

1 Scopus citations

Original language	English (US)
Title of host publication	Advances in Experimental Medicine and Biology
Pages	115-129
Number of pages	15
DOIs	https://doi.org/10.1007/978-1-4615-3398-6_12
State	Published - 1992

Publication series

Name	Advances in Experimental Medicine and Biology
Volume	324

ASJC Scopus subject areas

General Biochemistry, Genetics and Molecular Biology

Access to Document

10.1007/978-1-4615-3398-6_12

Cite this

@inproceedings{0ed8f96a13c54f678175bfceb909bf1c,

title = "Hormone refractory prostatic cancer: The role of radiolabelled diphosphonates and growth factor inhibitors",

author = "Scher, {H. I.} and T. Curley and S. Yeh and W. Tong and O'Moore, {P. V.} and S. Larson",

year = "1992",

doi = "10.1007/978-1-4615-3398-6_12",

language = "English (US)",

series = "Advances in Experimental Medicine and Biology",

pages = "115--129",

booktitle = "Advances in Experimental Medicine and Biology",

}

TY - GEN

T1 - Hormone refractory prostatic cancer

T2 - The role of radiolabelled diphosphonates and growth factor inhibitors

AU - Scher, H. I.

AU - Curley, T.

AU - Yeh, S.

AU - Tong, W.

AU - O'Moore, P. V.

AU - Larson, S.

PY - 1992

Y1 - 1992

UR - http://www.scopus.com/inward/record.url?scp=0027076841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027076841&partnerID=8YFLogxK

U2 - 10.1007/978-1-4615-3398-6_12

DO - 10.1007/978-1-4615-3398-6_12

M3 - Conference contribution

C2 - 1283494

AN - SCOPUS:0027076841

T3 - Advances in Experimental Medicine and Biology

SP - 115

EP - 129

BT - Advances in Experimental Medicine and Biology

ER -

Hormone refractory prostatic cancer: The role of radiolabelled diphosphonates and growth factor inhibitors

Publication series

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this